https://www.avient.com/sites/default/files/2020-10/photovoltaic-floating-power-station-case-study.pdf
While
solar power is touted as a viable option to meet
the growing demand, development of land-based
photovoltaic power stations is limited in some cases
by the cost of land, and in others by less-than-optimal
amounts of sunlight.
https://www.avient.com/sites/default/files/2021-07/plastiward-flyer-global.pdf
Standing apart
from other industry solutions,
PLASTIWARD is a fully
integrated turnkey solution
empowering your enforcement
team to take swift action
against fraud.
https://www.avient.com/sites/default/files/2020-10/antimicrobial-dental-case-study.pdf
As an added
benefit, Avient designed a universal carrier that enabled
the manufacturer to use the same additives across a
variety of olefins, elastomers, and other resins.
https://www.avient.com/sites/default/files/2021-12/avient-investor-day-registration-details21.pdf
Patterson and other senior
executives.
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520-%2520Investor%2520Day%25205-18-15.pdf
PolyOne Corporation Page 1
Investor Day
May 18, 2015
PolyOne Corporation Page 2
Forward-Looking Statements
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of
the Private Securities Litigation Reform Act of 1995.
They use words such as “will,”
“anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning in connection with any discussion of
future operating or financial performance and/or sales
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
Our ability to realize anticipated savings and operational benefits from the realignment of assets, including the planned closure of certain manufacturing
facilities;
The timing of closings and shifts of production to new facilities related to asset realignments and any unforeseen loss of customers and/or disruptions of
service or quality caused by such closings and/or production shifts;
Separation and severance amounts that differ from original estimates and amounts for non-cash charges related to asset write-offs and accelerated
depreciation realignments of property, plant and equipment, that differ from original estimates;
Our ability to identify and evaluate acquisition targets and consummate acquisitions;
The ability to successfully integrate acquired companies into our operations, retain the management teams of acquired companies and retain relationships
with customers of acquired companies including, without limitation, Spartech Corporation and Accella Performance Materials;
Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of
credit in the future;
The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate
liquidity) to maintain their credit availability;
The speed and extent of an economic recovery, including the recovery of the housing market;
Our ability to achieve new business gains; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
Changes in polymer consumption growth rates and laws and regulations regarding the disposal of plastic materials in jurisdictions where we conduct
business;
Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online in the industries in which we participate;
Fluctuations in raw material prices, quality and supply and in energy prices and supply;
Production outages or material costs associated with scheduled or unscheduled maintenance programs;
Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital
reductions, cost reductions and employee productivity goals;
An inability to raise or sustain prices for products or services;
An inability to maintain appropriate relations with unions and employees;
Our ability to continue to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
The amount and timing of repurchases of our common shares, if any;
Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and
changes in the rate of inflation
The above list of factors is not exhaustive
https://www.avient.com/sites/default/files/2024-03/QF-02 QMS Global Standard Response.PDF
Some have additional certifications such as
ISO 13485, ISO 14000, ISO 22000 and other third-party certified standards such as Responsible Care® and
IATF.
Product Complaint Timeline
In the event you have a quality issue or concern with an Avient product, please contact your sales
representative, provide as much detail as possible, and records, data, and other supporting information.
These
standards are designed to mitigate potential health
risks related to food products and or nutraceutical
products from their packaging and/or any other
material that may come into direct contact with it.
https://www.avient.com/sites/default/files/resources/Novel_Thermoplastic_Elastomers_with_Universal_Bonding_Characteristics.pdf
However, their adhesion on other substrates is poor.
The failure mode is cohesive on PP and adhesive on all other substrates.
Compared to other substrates, Nylon and polyacetal, i.e., POM,
appear to be difficult to bond.
https://www.avient.com/sites/default/files/resources/11.30.18%2520Investor%2520Presentation%2520V1.pdf
Investor Day
P O L Y O N E
I N V E S T O R
P R E S E N T A T I O N
N O V E M B E R 2 0 1 8
F O R W A R D L O O K I N G S T A T E M E N T S
PolyOne Corporation 2
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements”
within the meaning of the Private Securities Litigation Reform Act of 1995.
They use words such as “will,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other
words and terms of similar meaning in connection with any discussion of future operating or financial performance and/or sales.
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
• Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the
availability and cost of credit in the future;
• The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
• Changes in polymer consumption growth rates and laws and regulations regarding the disposal of plastic in jurisdictions where we
conduct business;
• Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;
• Fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated
with scheduled or unscheduled maintenance programs;
• Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
• An inability to raise or sustain prices for products or services;
• Information systems failures and cyber attacks; and
• Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in
interest rates and changes in the rate of inflation.
https://www.avient.com/sites/default/files/resources/PDI_Healthcare_Brochure_2011_0.pdf
PDI has extensive experience with
the testing of medical devices and
materials including:
• Catheters
• Bio-implants
• Surgical diagnostic devices
• Medical tubing
• Other disposable medical devices
Issues often arise as a result of:
• Improper design or choice of material
• The environment of exposure
• Processing conditions
World-class people and capabilities
under one roof
• Failure Analysis/Prevention
• Qualifi cation Support
• Rheology
• Polymer Characterization
• Deformulation
• Physical Testing
• Litigation Support
• Characterization of polymers in pharmaceutical
delivery systems
• Phthalate and BPA testing
1 7 . 2
8 . 2 5 i n
8 . 5 i n
1 7
C M Y K HC_Industry bulletin_PDI_fi nal.indd REMAY 78810
TR: 16.5000" x 11.6875" and 17.000" x 11.000" Digital/IAM
BL: 17.2500" x 11.9375"
FINAL: 8.2500" x 11.6875" and 8.500" x 11.000"
11
.6
8
7
5
in
2 5 i n
11
.9
3
7
5
in
8 . 2 5 i n
8 . 5 i n
11
in
i n
Asset No. 78810
Polymer Diagnostics Inc.
PDI has extensive experience with
the testing of medical devices and
materials including:
• Catheters
• Bio-implants
• Surgical diagnostic devices
• Medical tubing
• Other disposable medical devices
Issues often arise as a result of:
• Improper design or choice of material
• The environment of exposure
• Processing conditions
World-class people and capabilities
under one roof
• Failure Analysis/Prevention
• Qualifi cation Support
• Rheology
• Polymer Characterization
• Deformulation
• Physical Testing
• Litigation Support
• Characterization of polymers in pharmaceutical
delivery systems
• Phthalate and BPA testing
1 7 . 2
8 . 2 5 i n
8 . 5 i n
1 7
C M Y K HC_Industry bulletin_PDI_fi nal.indd REMAY 78810
TR: 16.5000" x 11.6875" and 17.000" x 11.000" Digital/IAM
BL: 17.2500" x 11.9375"
FINAL: 8.2500" x 11.6875" and 8.500" x 11.000"
11
.6
8
7
5
in
2 5 i n
11
.9
3
7
5
in
8 . 2 5 i n
8 . 5 i n
11
in
i n
Asset No. 78810
www.polymerdiagnostics.com
I n d u s t r y B u l l e t i n
Polymer Diagnostics Inc.
https://www.avient.com/sites/default/files/2024-03/ISO 9001 - NL027324 Current.pdf
Other sites are listed on the appendix.